AAP Releases 2025 Immunization Schedule, Taking a Stance Divergent from Federal Health Agencies
Pharm'Up 
The American Academy of Pediatrics (AAP) has issued its own 2025 child and adolescent immunization schedule, a move that directly contrasts with recent guidance from the CDC’s Advisory Committee on Immunization Practices (ACIP). The AAP stated its recommendations are based on decades of scientific evidence and are designed to support the health of children and families.
Major Divergences in Recommendations
The AAP’s new guidelines are notably more assertive on certain vaccines, creating a point of friction with federal health agencies.
- COVID-19 Vaccination: The AAP recommends universal COVID-19 vaccination for children between 6 and 23 months old. For older children (ages 2 to 18), they advise a risk-based approach, targeting those who are medically vulnerable or live with high-risk individuals. This contrasts with the CDC’s recent shift to a more cautious, shared clinical decision-making model for COVID-19 vaccines in children.
- Respiratory Illnesses: The AAP’s guidance also differs on other respiratory illnesses. It recommends RSV protection for infants under 8 months and for high-risk children aged 8 to 19 months during their second RSV season. For influenza, the AAP continues to advocate for an annual vaccine for children beginning at 6 months of age, including the use of thimerosal-containing formulations if necessary. This stands in opposition to a new ACIP preference for preservative-free flu vaccines.
The Context Behind the Breakaway
The AAP’s decision comes amid a period of heightened debate and skepticism surrounding vaccine policy. The article notes that recent actions by federal health agencies, including the reconstitution of the ACIP by HHS Secretary Robert F. Kennedy, Jr., and the CDC’s shift on COVID-19 vaccine recommendations for children, have been criticized for potentially undermining decades of evidence-based guidance.
The AAP’s release of its own schedule underscores the need for trusted health professionals to provide clear, consistent, and science-based information to the public. The article highlights that pharmacists, as one of the most accessible healthcare providers, will play a crucial role in helping families navigate these conflicting recommendations and uphold public health amid unprecedented challenges to vaccine confidence.
About the Author
